| Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ... New England Journal of Medicine 385 (24), e83, 2021 | 931 | 2021 |
| Global matrix 2.0: report card grades on the physical activity of children and youth comparing 38 countries MS Tremblay, JD Barnes, SA González, PT Katzmarzyk, VO Onywera, ... Journal of physical activity and health 13 (s2), S343-S366, 2016 | 574 | 2016 |
| Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 520 | 2022 |
| BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ... Nature medicine 27 (12), 2136-2143, 2021 | 484 | 2021 |
| Protection against the Omicron variant from previous SARS-CoV-2 infection HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ... New England Journal of Medicine 386 (13), 1288-1290, 2022 | 444 | 2022 |
| mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ... Nature medicine 27 (9), 1614-1621, 2021 | 427 | 2021 |
| Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 403 | 2022 |
| Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting LJ Abu-Raddad, H Chemaitelly, JA Malek, AA Ahmed, YA Mohamoud, ... Clinical Infectious Diseases 73 (7), e1830-e1840, 2021 | 243 | 2021 |
| Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 241 | 2022 |
| SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek, AA Ahmed, ... EClinicalMedicine 35, 2021 | 195 | 2021 |
| Knowledge, attitude and practices regarding cervical cancer and screening among women visiting primary health care in Qatar. FM Al-Meer, MT Aseel, J Al-Khalaf, MG Al-Kuwari, MF Ismail EMHJ 17 (11), 2011 | 175 | 2011 |
| Association of prior SARS-CoV-2 infection with risk of breakthrough infection following mRNA vaccination in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, HM Yassine, FM Benslimane, ... Jama 326 (19), 1930-1939, 2021 | 164 | 2021 |
| Beliefs and attitudes about breast cancer and screening practices among Arab women living in Qatar: a cross-sectional study TT Donnelly, AH Al Khater, SB Al-Bader, MG Al Kuwari, N Al-Meer, ... BMC women's health 13, 1-16, 2013 | 156 | 2013 |
| Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic LJ Abu-Raddad, H Chemaitelly, HH Ayoub, Z Al Kanaani, A Al Khal, ... Scientific reports 11 (1), 6233, 2021 | 148 | 2021 |
| Protective effect of previous SARS-CoV-2 infection against omicron BA. 4 and BA. 5 subvariants HN Altarawneh, H Chemaitelly, HH Ayoub, MR Hasan, P Coyle, ... New England Journal of Medicine 387 (17), 1620-1622, 2022 | 122 | 2022 |
| Arab women's breast cancer screening practices: a literature review TT Donnelly, AH Al Khater, SB Al-Bader, MG Al Kuwari, N Al-Meer, ... Asian Pacific Journal of Cancer Prevention 14 (8), 4519-4528, 2013 | 108 | 2013 |
| Duration of immune protection of SARS-CoV-2 natural infection against reinfection H Chemaitelly, N Nagelkerke, HH Ayoub, P Coyle, P Tang, HM Yassine, ... Journal of Travel Medicine 29 (8), taac109, 2022 | 105 | 2022 |
| Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar LJ Abu-Raddad, H Chemaitelly, R Bertollini New England Journal of Medicine 386 (11), 1091-1093, 2022 | 103 | 2022 |
| Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses LJ Abu-Raddad, H Chemaitelly, HM Yassine, FM Benslimane, ... Journal of travel medicine 28 (7), taab083, 2021 | 87 | 2021 |
| Prevalence and determinants of burnout syndrome among primary healthcare physicians in Qatar L Abdulla, DM Al-Qahtani, MG Al-Kuwari South African Family Practice 53 (4), 380-383, 2011 | 85 | 2011 |
